Shares in Adisyn Ltd (ASX: AI1) jumped 13% to A$0.13 after the US Patent and Trademark Office allowed the company's third patent, extending its graphene deposition intellectual property to non-metallic semiconductor surfaces. For a pre-revenue company built on the promise of replacing aging copper wiring inside advanced chips, the question is whether legal protection alone can bridge the gap to commercial reality.
Three Patents Now Cover Both Sides of the Chip's Wiring Interface. This third patent extends Adisyn's protection to non-metallic materials such as dielectrics, complementing two earlier allowed patents covering graphene deposition on metallic surfaces and resulting interconnect products.
Adisyn says the new protection gives it IP coverage across both sides of the barrier interface used in semiconductor interconnect structures. For shareholders, the practical payoff is that any would-be competitor now faces a wider wall of US patent claims — process, product, and surface type — making it harder to design around.
The Temperature Threshold Is the Real Technical Story. The patent's claims include a low-temperature process that keeps the underlying surface below 400°C, allowing graphene to be deposited and chemically bonded without damaging the material beneath it. That matters because conventional graphene deposition methods typically require high-temperature processes or catalytic metals that leave contaminating residues. Staying under the semiconductor industry's ~450°C thermal ceiling is a prerequisite for any chip factory to even consider the technology.
The Target Market Is Enormous, but Revenue Is Still Hypothetical. Adisyn is targeting chip architectures below five nanometres, where shrinking wire spacing increases the proportion of chip area consumed by barrier layers — what it calls the "barrier tax." It has demonstrated graphene deposition at approximately 1nm thickness, which it says could free up chip area for transistor density. Yet all demonstrations remain at coupon scale. The graphene deposition breakthrough was demonstrated on a one-centimetre-square coupon — an early-stage result.
Institutional Backing Provides a Financial Cushion — for Now. Adisyn raised A$14 million in April cornerstoned by Regal Funds Management (A$20 billion in assets) and Israel's Meitav (~A$190 billion in assets). That cash funds operations, but the stock has retreated sharply from its April highs near A$0.18. At A$0.13, the market is pricing patent progress but discounting the long road from lab coupon to wafer-scale production. Investors are buying legal protection over a promising material — not earnings.